Assignee
TETRALOGIC PHARM CORP
US·9 granted patents·6 pending applications·141 citations·filing 2005–2015
Top patents by PatentIndex Score
15 records- 0195US8022230B2Dimeric IAP inhibitorsTETRALOGIC PHARM CORP·Filed 2009·Granted Sep 20, 2011·25 cites·1 claims
- 0295US7456209B2IAP binding compoundsTETRALOGIC PHARM CORP·Filed 2005·Granted Nov 25, 2008·35 cites·16 claims
- 0393US8986993B2SMAC mimetic for treating myelodysplastic syndromesTETRALOGIC PHARM CORP·Filed 2013·Granted Mar 24, 2015·12 cites·4 claims
- 0493US7968590B2IAP binding compoundsTETRALOGIC PHARM CORP·Filed 2008·Granted Jun 28, 2011·19 cites·20 claims
- 0592US7985735B2Dimeric IAP inhibitorsTETRALOGIC PHARM CORP·Filed 2007·Granted Jul 26, 2011·19 cites·40 claims
- 0691US8822525B2Dimeric IAP inhibitorsTETRALOGIC PHARM CORP·Filed 2013·Granted Sep 2, 2014·12 cites·21 claims
- 0790US8802716B2IAP binding compoundsTETRALOGIC PHARM CORP·Filed 2013·Granted Aug 12, 2014·9 cites·26 claims
- 0889US9187490B2Dimeric IAP inhibitorsTETRALOGIC PHARM CORP·Filed 2014·Granted Nov 17, 2015·8 cites·5 claims
- 0979US9394249B2IAP binding compoundsTETRALOGIC PHARM CORP·Filed 2014·Granted Jul 19, 2016·2 cites·15 claims
- 1059US2015158908A1SMAC Mimetic for Treating Myelodysplastic SyndromesTETRALOGIC PHARM CORP·Filed 2015·Application pending·0 cites
- 1157US2013040893A1Treatment of proliferative disordersTETRALOGIC PHARM CORP·Filed 2012·Application pending·0 cites
- 1250US2013274278A1Iap inhibitorsTETRALOGIC PHARM CORP·Filed 2013·Application pending·0 cites
- 1345US2014303090A1Smac Mimetic TherapyTETRALOGIC PHARM CORP·Filed 2014·Application pending·0 cites
- 1438US2011008802A1TNFalpha GENE EXPRESSION AS A BIOMARKER OF SENSITIVITY TO ANTAGONISTS OF INHIBITOR OF APOPTOSIS PROTEINSTETRALOGIC PHARM CORP·Filed 2008·Application pending·0 cites
- 1536US2015190470A1Combination therapyTETRALOGIC PHARM CORP·Filed 2013·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →